For services or facilities that provide chemotherapy treatments, commonly used P-list and U-list substances are highly toxic and dangerous. If disposed of improperly, these wastes may cause irreparable damage to natural resources. The EPA mandates that chemotherapy waste must be separated, properly packaged and labeled, and required to be disposed of in special containers. At BWS, we have expert knowledge and experience in Trace & Bulk Chemotherapy Waste disposal, safely handling, transporting, and treatment of the various types of chemotherapy waste.
Trace Chemotherapy Waste
Trace chemotherapy waste generally includes empty vials, bags, IV tubes, and other items that used to contain chemotherapy drugs, but now qualify as “RCRA empty.” To qualify as “trace”, all removable contents must be eliminated with less than 3% of the former volume left. This also includes items generated in the preparation and administration of antineoplastic/cytotoxic drugs, such as gloves or gowns that are not visibly contaminated. If the applicable criteria are met, then this waste can be considered trace waste and can be managed as regulated medical waste and disposed of in special containers. Otherwise, it should be managed as hazardous waste.
Bulk Chemotherapy Waste
Bulk chemotherapy waste usually includes items that used to contain chemotherapy agents and that don’t qualify as “RCRA empty”, such as full bags or bottles, and P-listed chemo drugs. Other types of bulk waste include materials used to clean up chemo spills and visibly contaminated protective equipment.
RCRA waste requires specialized containment to ensure compliant disposal. Our hazardous waste division at BWS works with each client to provide the correct containers and the most effective collection, transport, and disposal options available.
